SCHEMBL7295129

SCHEMBL7295129

Cc1[nH]cnc1-c1ccncc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.51
MAPK13 O15264 2/20 0.51
MAPK12 P53778 2/20 0.51
MAPK11 Q15759 2/20 0.51
RAF1 P04049 1/20 0.51
MAPK9 P45984 1/20 0.51
BRAF P15056 1/20 0.41
CCNB2 O95067 1/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
CCNA1 P78396 1/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
CCNB3 Q8WWL7 1/20 0.41
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.40
KDM4E B2RXH2 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22434856 0.81 ADORA3 (0.50) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL8002000 0.81 KDM4E (0.61) MAPK14CCNB2CDK1CCNB1CCNA2
SCHEMBL29445964 0.81 CYP2D6 (0.45) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL19396824 0.79 DYRK1A (0.43) MAPK14MAPK13MAPK12MAPK11CCNB2
SCHEMBL3141937 0.78 ASIC3 (0.41) MAPK14MAPK13MAPK12MAPK11RAF1
Lofemizole SCHEMBL35441 0.78 ADORA3 (0.47) CCNB2CDK1CCNB1CDK5CDK5R1
SCHEMBL21428970 0.78 MAPK14 (0.54) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL5717900 0.77 KIF11 (0.42) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL2691682 0.77 CYP2A6 (0.56) MAPTLMNAKDM4ECYP3A4
SCHEMBL17675495 0.77 IDO1 (0.47) MAPK14MAPK13MAPK12MAPK11RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024123967-A1 SARM1 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS SENYA PHARMACEUTICALS, INC. (US) 2024-06-13 WO disclosed
EP-0507650-B1 Piperidine derivatives, their preparation and their therapeutic application SYNTHELABO (FR) 1996-05-22 EP disclosed
US-5434169-A Piperidine derivatives, their preparation and their application in therapy SYNTHELABO (FR) 1995-07-18 US disclosed
US-5418241-A Antiserotonin agents SYNTHELABO (FR) 1995-05-23 US disclosed
EP-0646583-A1 Derivatives of Imidezol-4-yl piperidine, their preparation and use in therapy SYNTHELABO (FR) 1995-04-05 EP disclosed
EP-0591027-A1 Piperidine derivatives, their preparation and their use as medicine SYNTHELABO (FR) 1994-04-06 EP disclosed
EP-0591026-A1 Piperidine derivatives, their preparation and their use in therapy SYNTHELABO (FR) 1994-04-06 EP disclosed
US-5280030-A Containing 1-benz(oxazole, thiazole or imidazole)-4-imidazole piperidine compound SYNTHELABO (FR) 1994-01-18 US disclosed
EP-0507650-A1 Piperidine derivatives, their preparation and their therapeutic application SYNTHELABO (FR) 1992-10-07 EP disclosed